Kristina Schmidt-Lassen

Title: Innovations by Kristina Schmidt-Lassen

Introduction

Kristina Schmidt-Lassen is a notable inventor based in Kiel, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target potassium channels. Her work has implications for treating various diseases, including autoimmune disorders.

Latest Patents

Kristina Schmidt-Lassen holds 2 patents. Her latest patents include innovations related to 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage-gated Kv1.3 potassium channel. These compounds are designed to treat diseases or disorders in both human and animal subjects. They inhibit potassium channels, specifically the Kv1.3 channel, and some therapeutic effects may be attributed to this inhibition. The compounds are noted for their selectivity, being more effective against certain potassium channels, such as Kv1.3, compared to others like Kv1.5.

Career Highlights

Kristina Schmidt-Lassen is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential to address significant health challenges through innovative chemical solutions.

Collaborations

She collaborates with esteemed colleagues, including Heike Wulff and Ananthakrishnan Sankaranarayanan, to advance her research and explore new avenues in medicinal chemistry.

Conclusion

Kristina Schmidt-Lassen's contributions to the field of medicinal chemistry highlight her innovative spirit and dedication to improving health outcomes through her inventions. Her work continues to pave the way for new treatments for autoimmune diseases and beyond.